(MENAFN- GlobeNewsWire - Nasdaq) JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...

Operator: Good morning, and welcome to the Par Pacific Third Quarter Earnings Call. [Operator Instructions] I would now like to turn the conference over to Ashimi Patel, Vice President of Investor ...

Par Pacific Holdings Inc. reported a significant earnings surprise for Q3 2025, with earnings per share (EPS) of $5.95, compared to the forecasted $1.84. This represents a remarkable surprise of ...

Adjusted EBITDA for the third quarter was $372 million, including approximately a $200 million boost from small refinery exemptions. Adjusted net income for the third quarter was $5.95 per share, ...